panaxadiol has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, X; Fu, H; Fu, T; Guo, H; Shan, Y; Xie, N | 1 |
1 other study(ies) available for panaxadiol and Pancreatic Neoplasms
| Article | Year |
|---|---|
Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer.
Topics: Cell Line, Tumor; Cell Proliferation; Ginsenosides; Humans; Janus Kinase 2; Models, Molecular; Molecular Structure; Pancreatic Neoplasms; Signal Transduction; STAT3 Transcription Factor | 2021 |